ritanserin has been researched along with racemetirosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, H; Kamei, H; Mamiya, T; Miyamoto, Y; Nabeshima, T; Noda, Y | 1 |
| Gresch, PJ; Walker, PD | 1 |
| Matsushima, K; Tozawa, Y | 1 |
3 other study(ies) available for ritanserin and racemetirosine
| Article | Year |
|---|---|
Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly.
Topics: alpha-Methyltyrosine; Animals; Benzazepines; Cocaine; Conditioning, Psychological; Male; Mice; Oxidopamine; Phencyclidine; Receptors, Dopamine D1; Receptors, Serotonin; Ritanserin | 1998 |
Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor.
Topics: alpha-Methyltyrosine; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Enzyme Inhibitors; Gene Expression; Male; p-Chloroamphetamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Ritanserin; RNA, Messenger; Serotonin Agents; Serotonin Antagonists; Substance P; Tachykinins | 1999 |
Peripheral 5-HT(2A)-receptor-mediated formation of an inhibitor of atrial natriuretic peptide binding involves inflammation.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atrial Natriuretic Factor; Catecholamines; Cyclooxygenase Inhibitors; Dexamethasone; Ditiocarb; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Indomethacin; Inflammation; Isatin; Ketanserin; Muscle, Smooth; Prazosin; Propranolol; Protein Binding; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2A; Receptors, Angiotensin; Receptors, Serotonin; Reserpine; Ritanserin; Serotonin; Serotonin Receptor Agonists; Tyrosine 3-Monooxygenase; Urination; Vascular Resistance; Yohimbine | 2002 |